Navigation Links
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
Date:7/29/2010

------------------- Net loss and comprehensive loss for the period 4,351,974 4,334,757 8,493,185 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Basic and diluted loss per share 0.07 0.09 0.14 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Weighted average number of shares (basic and diluted) 61,556,343 47,449,182 61,553,173 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Cumulative from inception Six Month on April 2, Period 1998 to Ending June June 30, 30, 2009 2010 $ $ ----------------------------------------------------------- Revenue Rights revenue - 310,000 ----------------------------------------------------------- - 310,000 Expenses Research and development 6,051,865 92,538,772 Operating 1,967,485 30,702,275 Stock based compensation 20,181 5,195,545 Foreign exchange loss/(gain) 59,138 766,293 Amortization - intellectual property 180,750 3,615,000 Amortization - property and equipment 33,840
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent
2. Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
3. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
4. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
5. Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
6. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting
7. Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
8. Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
9. Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results
10. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
11. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... LAS VEGAS , July 31, 2015 /PRNewswire/ ... pharmacists seek resources that help them drive positive ... as a vital source of patient care in ... Pharmacy,s annual tradeshow and conference, AmerisourceBergen announced ... strengthen its Pharmacy Services Administration Organization and help ...
(Date:7/31/2015)... 31, 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, ... today announced that the Company has filed its Annual ... Exchange Commission. The filed Form 20-F includes audited financial ... The Form 20-F can be accessed by visiting the ...
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that it is ... to be held August 5-9 in Marshall. The Ralco Enrichment Center is an interactive ... how agriculture impacts their daily lives. This unique exhibit also features a birthing center ...
(Date:7/30/2015)... Mass. , July 30, 2015   ... solutions for the interpretation and analysis of genomic ... Matthew Fischer has joined the company as ... Photo - http://photos.prnewswire.com/prnh/20150730/250931 ... capabilities to integrate, interpret, analyze and explore complex ...
Breaking Biology Technology:AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2
... Isolation from E. coli Using the Eppendorf<sup , ... Plasmid Mini , Kit , , ... Joel Lopez, Melissa Higgins, Chere Griffin and Vince Prezioso, PhD , ... Introduction , Isolation and purification of plasmid DNA from bacteria ...
... or pathogens , Gabriela M. Tobal ,Stratagene ... Stratagene is introducing PCR primer sets ... these primers have been published previously,and are well ... use PCR technology to identify the presence of ...
... New PathDetect reporting system for ... Matthew Hsu Mary Buchanan Chao-Feng Zheng ... plasmid,the pNFAT-Luc reporter plasmid, is designed for studying ... (NFAT) transcription factors. These,interesting proteins, which play an ...
Cached Biology Technology:Comparison of Growth Techniques and Media for the Purpose of Plasmid , Isolation from E. coli Using the Eppendorf , Perfectprep Plasmid Mini , Kit 2Comparison of Growth Techniques and Media for the Purpose of Plasmid , Isolation from E. coli Using the Eppendorf , Perfectprep Plasmid Mini , Kit 3Comparison of Growth Techniques and Media for the Purpose of Plasmid , Isolation from E. coli Using the Eppendorf , Perfectprep Plasmid Mini , Kit 4New PCR Primers for Human Diseases 2New PCR Primers for Human Diseases 3New PCR Primers for Human Diseases 4Cis-Reporting System Monitors Intracellular Calcium Mobilization 2Cis-Reporting System Monitors Intracellular Calcium Mobilization 3Cis-Reporting System Monitors Intracellular Calcium Mobilization 4Cis-Reporting System Monitors Intracellular Calcium Mobilization 5
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
(Date:7/31/2015)... The 10 th International Conference on Genomics ... 22-25, 2015, in Shenzhen , ... 10 th anniversary this year. Since its inauguration in ... annual meetings in the ,omics, fields, and is one of ... ICG-10 focuses on recent breakthroughs and advances in ,omics, ...
(Date:7/23/2015)... July 23, 2015 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... 2015 was $4.5 million, a decrease of 33% compared to ... in the second quarter of 2015 was $0.3 million, or ... $0.04 per diluted share, in the same period a year ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... species of sharks and redfish captured in waters off ... free-swimming fish harbored several drug-resistant bacterial strains. ... and Wildlife Medicine , found antibiotic-resistant bacteria in every ... bacteria in fish at nearly all of the study ...
... - Haze, scientifically known as atmospheric aerosols - microscopic ... major environmental problem because it degrades visibility, affects human ... how the haze is formed is not fully understood, ... and chemistry who has studied air chemistry for more ...
... Eyjafjallajokull volcano woke from its nearly 200-year slumber to change ... transatlantic air travel to a halt for the first time ... these forces of nature contain and of our relative ... Department of Geology & Geophysics has published research in the ...
Cached Biology News:Wild sharks, redfish harbor antibiotic-resistant bacteria 2Research is getting closer to understanding critical nucleus in haze formation, prof says 2LSU professor uses volcanic emissions to study Earth's atmospheric past 2LSU professor uses volcanic emissions to study Earth's atmospheric past 3
Component in MasterPure™ Purification Kits...
Anti-gp340 Monoclonal Antibody Description: 100 g Research Focus: cancer & cell proliferation Storage: -20C Shipping Temperature: 4C...
Mouse anti-HIV-Imn PND Class: Antibody Product Group: Bacterial and Viral Antigen...
... BRF2 Immunogen Synthetic peptide: QAARQAATSVPNPP, corresponding ... BRF2. Reactivity / Specificity Cross-reacts with ... Background Information BRF2 is one of the ... factor complex required for transcription of genes with ...
Biology Products: